Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 117635
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117635
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117635
Figure 5 Zuo Gui pill and Fer-1 regulate M1 macrophage polarization and nuclear factor E2-related factor 2 signaling pathway in type 2 diabetic osteoporosis bone marrow.
A: M1 macrophage polarization level in bone marrow; B: Nuclear factor E2-related factor 2 (Nrf2), hemoxygenase-1 (HO-1), glutathione peroxidase 4 (GPX4), XCT, FTH1, and related mRNA expression of bone metabolism proteins receptor activator of nuclear factor-kappa B and RUNX2 in bone tissue; C: Protein associated with Nrf2, HO-1, GPX4, and XCT in bone tissue; D: Immunohistochemical staining of Nrf2, HO-1, and GPX4 in bone tissue visualized under a microscope (scale bar: 200 µm). Data were expressed as mean ± SD (n = 3). aP < 0.05,bP < 0.01,cP < 0.001. GPX4: Glutathione peroxidase 4; HO-1: Hemoxygenase-1; MET: Metformin; Nrf2: Nuclear factor E2-related factor 2; ZGP: Zuo Gui pill; Rankl: Receptor Activator of Nuclear Factor κB Ligand; Runx2: Runt-related Transcription Factor 2.
- Citation: Zhao Y, Feng XZ, Cao WQ, Chen YR, Yang Y, Liu JC, Xu A, Ren YL, Wang ZM. Zuo Gui pill alleviates M1 macrophage polarization in type 2 diabetic osteoporosis through the Nrf2/HO-1/XCT/GPX4 pathway. World J Diabetes 2026; 17(5): 117635
- URL: https://www.wjgnet.com/1948-9358/full/v17/i5/117635.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i5.117635